Sugawara Risa, Usui Yoshihiko, Takahashi Reisuke, Nagao Toshitaka, Goto Hiroshi
Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan.
Department of Diagnostic Pathology, Tokyo Medical University, Tokyo, Japan.
Am J Ophthalmol Case Rep. 2022 Jan 31;25:101382. doi: 10.1016/j.ajoc.2022.101382. eCollection 2022 Mar.
T-Lymphoblastic lymphoma (T-LBL) is a rare malignant tumor originated from precursor T-lymphocytes that differentiate to T lymphocytes. We report a rare case of T-LBL presenting with conjunctival mass as the first sign.
A 61-year-old man presented with a right salmon colored conjunctival mass. A biopsy was performed, and histopathologic examination showed dense lymphocyte proliferation in subepithelial substantia propria. Immunohistochemical staining was positive for CD7, CD10, and TdT; and negative for CD20. CD3 was negative in most parts PET-CT revealed abnormal uptake in the left cervix, anterior mediastinum, abdominal aortic lymph nodes, and multiple bones. From the above findings, stage IVA T-LBL was diagnosed. The patient received hyper CVAD therapy (cyclophosphamide + doxorubicin + vincristine + dexamethasone) and HD-MA therapy (high-dose methotrexate + cytarabine). Subsequently, an unrelated bone marrow transplant was performed.
This case demonstrates the importance of considering rare lymphomas such as T-LBL in the differential diagnosis of ocular adnexal lymphoid neoplasms.
T淋巴细胞母细胞淋巴瘤(T-LBL)是一种起源于前体T淋巴细胞并分化为T淋巴细胞的罕见恶性肿瘤。我们报告一例罕见的以结膜肿物为首发症状的T-LBL病例。
一名61岁男性患者出现右侧鲑鱼色结膜肿物。进行了活检,组织病理学检查显示上皮下固有层淋巴细胞密集增殖。免疫组化染色CD7、CD10和TdT呈阳性;CD20呈阴性。大部分区域CD3呈阴性。PET-CT显示左侧颈部、前纵隔、腹主动脉旁淋巴结及多骨摄取异常。根据上述结果,诊断为ⅣA期T-LBL。患者接受了Hyper CVAD方案(环磷酰胺+阿霉素+长春新碱+地塞米松)和HD-MA方案(大剂量甲氨蝶呤+阿糖胞苷)治疗。随后,进行了非亲缘异基因骨髓移植。
该病例表明在眼附属器淋巴样肿瘤的鉴别诊断中考虑T-LBL等罕见淋巴瘤的重要性。